ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $24,572 | $14,137 | $32,561 | $48,268 |
| - Cash | $13,291 | $12,598 | $7,956 | $21,426 |
| + Debt | $0 | $0 | $0 | $4,939 |
| Enterprise Value | $11,281 | $1,538 | $24,606 | $31,781 |
| Revenue | $0 | $0 | $0 | $8 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$10,445 | $0 | -$5,843 |
| % Margin | – | – | – | -71,796.9% |
| EBITDA | $2,856 | -$17,810 | -$17,769 | -$9,328 |
| % Margin | – | – | – | -114,612.9% |
| Net Income | $2,779 | -$17,506 | -$18,062 | -$9,658 |
| % Margin | – | – | – | -118,662.2% |
| EPS Diluted | 2.75 | -35.5 | -42.5 | -41.75 |
| % Growth | 107.7% | 16.5% | -1.8% | – |
| Operating Cash Flow | -$27,182 | -$10,844 | -$17,034 | -$9,442 |
| Capital Expenditures | $0 | $0 | -$2 | -$6 |
| Free Cash Flow | -$27,182 | -$10,844 | -$17,036 | -$9,448 |